Microalbuminuria and cardiovascular risk

QJM: An International Journal of Medicine

Volumn 91, Issue 6, 1998, Pages 381-391

  Lydakis, C ^a   Lip, G Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; LIPID; VON WILLEBRAND FACTOR;

ARTERY DISEASE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MICROALBUMINURIA; PRIORITY JOURNAL; PROTEIN URINE LEVEL; REVIEW; STROKE;

EID: 0031831224     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/91.6.381     Document Type: Review

References (114)

1. Kaysen JA, Myers BD, Cowser DC, Rabkin R, Felts JM. Mechanisms and consequences of proteinuria. Lab Invest 1985; 54:479-98.
2. Noth R, Krolewski A, Kaysen G, Meyer T, Schambelan M. Diabetic Nephropathy: Hemodynamic basis and implications for disease management. Ann Intern Med 1989; 110:795-813.
3. Shihabi Z, Konen J, O'Connor M. Albuminuria vs. urinary total protein for detecting chronic renal disorders. Clin Chem 1991; 37(5):621-4.
4. Viberti GC, Hill RD, Jarret RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982; 1:1430-2.
5. Parving HH, Jensen HA, Mogensen CE, Evrin PE. Increased urinary albumin excretion rate in benign hypertension. Lancet 1974; i:1190-2.
6. Mogensen CE. Systemic blood pressure and glomerular leakage with particular reference to diabetes and hypertension. J Inter Med 1994; 235:297-316.
7. Metcalf P, Baker J, Scott A, Wild C, Scragg R, Dryson A. Albuminuria in people at least 40 years old: Effect of obesity, hypertension and hyperlipidemia. Clin Chem 1992; 38(9):1802-8.
8. Howey JEA, Browning MCK, Fraser CG. Selecting the optimum specimen for assessing slight albuminuria and a strategy for clinical investigation: novel use of data on biological evaluation. Clin Chem 1987; 33:2034-8.
9. Catling W, Knight C, Hill RD. Screening for early diabetic nephropathy: which sample to detect microalbuminuria? Diabetic Med 1985; 2:451-5.
10. Feldt-Rasmussen B, Mathiesen ER. Variability of urinary albumin excretion in incipient diabetic nephropathy. Diabetic Nephropathol 1984; 3:101-3.
11. Cohen DL, Close CF, Viberti GC. The variability of overnight urinary albumin excretion in insulin dependent diabetic and normal subjects. Diabetic Med 1987; 4:437-40.
12. Marre M, Claudel JP, Ciret P, Luis N, Suarez L, Passa P. Laser immunonephelometry for routine quantification of urinary albumin excretion. Clin Chem 1987; 33:209-13.
13. Silver A, Dawnay A, Landon J, Cattell WR. Immunoassays for low concentrations for albumin in urine. Clin Chem 1986; 32:1303-6.
14. Viberti GC, Mogensen CE, Keen H, Jacobsen FK, Jarrett RG, Christensen CK. Urinary excretion of albumin in normal man: the effect of water loading. Scand J Clin Lab Invest 1982; 42:147-51.
15. Mimran A, Ribstein J, DuCailar G. Is microalbuminuria a marker of early intrarenal vascular dysfunction in essential hypertension? Hypertens 1994; 23(2):1018-21.
16. Metcalf P, Baker J, Scragg R, Dryson E, Scott A, Wild C. Microalbuminuria in a middle-aged workforce. Diabetes Care 1993; 16:1485-93.
17. Could MM, Ali MV, Goubet SA, Yadkin JS, Haines AP. Microalbuminuria: associations with height and sex in non diabetic subjects. Br Med J 1993; 306:240-2.
18. Haffner SM, Gonzales C, Valdez RA, Mycaanen L, Hazuda HP, Mitchell BD, Monterossa A, Stern MP. Is microalbuminuria part of the prediabetic state? The Mexico City Diabetes Study. Diabetologia 1993; 36:1002-6.
19. Jiang X, Srinivasan SR, Radhakrishnamurthy B, Dalferes ER, Bao W, Berenson GS. Microalbuminuria in young adults related to blood pressure in a biracial (black-white) population. Am J Hypertens 1994; 7:794-800.
20. Summerson JS, Bell RA, Konen JC. Racial differences in the prevalence of microalbuminuria in hypertension. Am J Kidney Dis 1995; 26(4):577-9.
21. Ritz E, Nowicki M, Fliser D, Horner D, Klin HP. Proteinuria and hypertension. Kidney Int 1994; 46 (Suppl 47):S76-80.
22. West JN, Gosling P, Dimmitt SB, Littler AW. Non-diabetic microalbuminuria in clinical practice and its relationship to posture, exercise and blood pressure. Clin Sci 1991; 81:373-7.
23. Erley CM, Grau C, Furian T, Braun N, Wolf S, Risler T. Exercise but not Angiotensin II infusion increases microalbuminuria in young patients with essential hypertension. (Abstract) J Hypertens 1994; 12(Suppl 3):S156.
24. Harmoinen A, Vuorinen P, Jokela H. Turbidimetric measurement of microalbuminuria. Clin Chim Acta 1987; 166:85-9.
25. Cambiaso CL, Collet-Cassart D, Lievens M. Immunoassay of low concentrations of albumin in urine by latex particle counting. Clin Chem 1988; 34:416-18.
26. McCormick CP, Konen JC, Shihabi ZK. Microtransferrinuria and albuminuria: enhanced immunoassay. Ann Clin Lab Sci 1989; 19:944-51.
27. Chavers BM, Simonson J, Michael AF. A solid face fluorescent immunoassay for the measurement of human urinary albumin (Tech Note). Kidney Int 1984; 25:576-8.
28. Niwa T, Katsuzaki T, Tatemicichi M, et al. Enzyme immunoassay for urinary albumin at low concentrations in diabetes mellitus. Clin Chim Acta 1990; 186:391-6.
29. Rowe DJF, Dawnay A, Watts GF. Microalbuminuria in diabetes mellitus: review and recommendations for measurement of albumin in urine. Ann Clin Biochem 1990; 27:297-312.
30. Mueller P, MacNeil M, Smith J, Miller D. Interlaboratory comparison of the measurement of albumin in urine. Clin Chem 1991; 37(2):191-5.
31. Dennis VW, Robinson RR. Proteinuria. In: Seldin DW, Giebisch G, eds. The Kidney: Physiology and pathophysiology. New York, Raven Press, 1985:1805-6.
32. Leeuw PW, Gaillard CA, Birkenhäger WH. The kidney in hypertension. In: Swales JD. Textbook of Hypertension. Blackwell Scientific Publications, Oxford, 1994:702.
33. van Hooft I, Grobbee D, Derk FH, de Leeuw PW, Schalelamp MA, Hofman A. Renal hemodynamics and the renin-angiotensin aldosterone system in normotensive subjects with hypertensive and normotensive parents. N Engl J Med 1991; 324:1305-11.
34. Hollenberg NK, Adams DF, Solomon H, Chenitz WR, Burger BM, Abrams BM, Abrams HL, Merill JP. Renal vascular tone in essential and secondary hypertension. Medicine 1975; 54:29-44.
35. Williams GH, Hollenberg NK. Accentuated vascular and endocrine response to SQ 20 881 in hypertension. New Engl J Med 1977; 297:184-8.
36. Ljungman S. Renal function, sodium excretion and the renin-angiotensin aldosterone system in relation to blood pressure. Acta Med Scand 1982; suppl 663:108.
37. Widgren BR, Herlitz H, Aurell M, Berglund G, Wilkstrand J, Andersson OK. Increased systemic and renal vascular sensitivity to angiotensin II in normotensive men with positive family histories of hypertension. Am J Hypertens 1992; 5:167-74.
38. Deen WM, Satvat B. Determinants of the glomerular filtration of proteins. Am J Physiol 1981; 241:F162-70.
39. Olivetti G, Kithier K, Giacomelli F, Wiener J. Characterisation of glomerular permeability and proteinuria in acute hypertension in the rat. Kidney Int 1984; 25:599-607.
40. Eisenbach GM, van Liew JB, Boylan JW, et al. Effect of angiotension on the filtration of protein in the rat kidney: a micropuncture study. Kidney Int 1975; 8:80-7.
41. Cottone S, Cottone A, D'Ignoto G, Zagarrigo C, Panepinto N, Cerasola G. Prevalence of microalbuminuria in essential hypertension. (Abstract) J Hypertens 1994; 12(Suppl 3):133.
42. Erley CM, Holzer M, Kramer BK, Risler T. Renal hemodynamics and organ damage in young hypertensive patients with different plasma renin activities after ace inhibition. Nephrol Dial Transplant 1992; 7:216-20.
43. Mimran A, Ribstein J. Microalbuminuria in essential hypertension. Clin Exp Hypertens. 1993; 15(6):1061-7.
44. Losito A, Fortunati F, Zampi I, Del Favero A. Impaired renal functional reserve and albuminuria in essential hypertension. Br Med J 1988; 96:1562-4.
45. Grunfeld B, Perelstein E, Simsolo R, Gimenez M, Romero J. Renal functional reserve and microalbuminuria in offspring of hypertensive parents. Hypertension 1990; 15:257-61.
46. Valvo E, Casagrande P, Bedogna V, Dalsanto F, Alberti D, Fontanarosa C et al. Renal function reserve in patients with essential hypertension: effect of inhibition of the renin-angiotensin system. Cli Sci 1990; 78:585-90.
47. Giaconi S, Levanti C, Fommei E, Innocenti F, Seghieri G, Palla L, et al. Microalbuminuria and casual ambulatory blood pressure in normotensives and in patients with borderline and mild essential hypertension. Am J Hypertens 1989; 2:259-61.
48. West JN, Gosling P, Dimmitt SB, Littler WA. Non-diabetic microalbuminuria in clinical practice and its relationship to posture, exercise and blood pressure. Clin Sci 1991; 81:373-7.
49. Schmieder R, Grube E, Ruddel H, Schlebusch H, Schulte W. Bedeutung der Mikroproteinurie zur Fruherkennung hypertoniebedingter Endorganschadigungen. Klin Wochenschr 1990; 68(5):256-62.
50. Cerasola G, Cottone S, D'Ignoto G, Grasso L, Mangano MT, Carapelle E, et al. Microalbuminuria as a predictor of cardiovascular damage in essential hypertension. J Hypertens 1989; 7(suppl 6):S332-3.
51. Cerasola G, Cottone S, D'Ignoto G, Fullantelli MA, Grasso L, Mangano MT, et al. Cattedra di fisiopatologia medica e centro ipertensione, Universita degli, Studi di Palermo Microalbuminuria, precose marker delle modificazioni renali nell' ipertensione essenziale. Ann Ital Med Int 1990; 5(3):180-5.
52. Redon J, Pascual GM, Mirrales A, Sanz C, Gutierrez M, Ros MJ, et al. Microalbuminuria en la hipertension arteriel essencial. Med Clin (Barc) 1991; 96(14):525-9.
53. Bianchi S, Bigazzi R, Baldari G, Sgherri G, Campese V. Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am J Hypertens. 1994; 7:23-9.
54. Opshal JA, Abraham PA, Halstenson CE, Kean WF. Correlation of office and ambulatory blood pressure measurement with urinary albumin and N-acetyl-a-D-glucosaminidase excretions in essential hypertension. Am J Hypertens 1988; 1(suppl 1):117S-20S.
55. Metcalf P, Baker J, Scragg R, Dryson E, Scott A, Wild C. Microalbuminuria in a middle-aged workforce. Diabetes Care 1993; 16:1485-93.
56. Gosling P, Beevers D. Urinary albumin excretion and blood pressure in the general population. Cli Sci 1989; 76:39-42.
57. Cruickshank JK, Anderson N, Haines A. 'Spot' urinary albumin/creatinine: a positive independent relation to systolic blood pressure in the general population: an index of vascular risk? (Abstract) Clin Sci 1987, 72(Suppl 16):43.
58. Haffner S, Stern M, Kozlowski Gruber K, Hazuda H, Mitchell B, Patterson J. Microalbuminuria. Potential marker for increased cardiovascular risk factors in nondiabetic subjects? Arteriosclerosis 1990; 10:727-31.
59. Gould MM, Ali MV, Goubet SA, Yadkin JS, Haines AP. Microalbuminuria: associations with height and sex in non diabetic subjects. Br Med J 1993; 306:240-2.
60. Haffner MS, Gonzales C, Valdez RA, Mycaanen L, Hazuda HP, Mitchell BD, et al. Is microalbuminuria part of the prediabetic state? The Mexico City Diabetes Study. Diabetologia 1993; 36:1002-6.
61. Gerber L, Schmukler C, Alderman M. Differences in urinary albumin excretion rate between normotensive and hypertensive white and non white subjects. Arch Intern Med 1992; 152:373-7.
62. Viberti GC, Hill RD, Jarret RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982; 1:1430-2.
63. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes. N Engl J Med 1984; 310:356-60.
64. Wolffenbuttel BH, Sels JP, Verhoeven S, Nieuwenhuijzen Kruseman AC. Diabetes regulatie en late complicaties bij poliklinisch behandelde patienten met diabetes mellitus type II. Ned Tijdschr Geneeskd 1991; 135(50):2387-91.
65. Noth R, Krolewski A, Kaysen G, Meyer T, Schambelan M. Diabetic Nephropathy: Hemodynamic basis and implications for disease management. Ann Intern Med 1989; 110:795-813.
66. Scholey JW, Meyer TW. Control of glomerular hypertension by insulin administration in diabetic rats. J Clin Invest 1989; 83:1384-9.
67. DeFronzo RA. The effect of insulin on renal sodium metabolism: a review with clinical implications. Diabetologia 1981; 21:165-71.
68. Agewall S, Persson B, Samuelsson O, Ljungman S, Herlitz H, Faberg B. Microalbuminuria in treated hypertensive men at high risk of coronary disease. J Hypertens 1993; 11:461-9.
69. Bianchi S, Bigazzi R, Valtriani C, Chiapponi I, Sgherri C, Baldari G, et al. Elevated serum insulin levels in patients with essential hypertension and microalbuminuria. Hypertension 1994; 23:681-7.
70. Shearman C, Gosling P. Microalbuminuria and vascular permeability. Lancet 1988; i:906-7.
71. Gosling P, Sutcliffe AJ, Cooper MACS, Jones AF. Burn and trauma associated proteinuria: the role of lipid peroxidation, renin and myoglobin. Ann Clin Biochem 1988; 25:53-9.
72. Mahmud N, Stinson J, O'Connel MA, Mantle TJ, Keeling PWN, Feely J, Weir DC, Kelleher D. Microalbuminuria in inflammatory bowel disease. Gut 1994; 35:1599-604.
73. Pedersen LM, Nordin H, Svensson B, Bliddal H. Microalbuminuria in patients with rheumatoid arthritis. Ann Rheum Dis 1995; 54:189-92.
74. Bar J, Hod M, Erman A, Friedman S, Gelerenter I, Kaplan B, et al. Microalbuminuria as an early predictor of hypertensive complications in pregnant women at high risk. Am J Kidney Dis 1996; 28:220-5.
75. Cecchi R, Seghierri G, Gironi A, Tuci A, Giomi A. Relation between urinary albumin excretion and skin involvement in patients with psoriasis. Dermatology 1992; 185:93-5.
76. Bigazzi R, Bianchi S, Campese VN, Baldari G. Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension. Nephron 1992; 61:94-7.
77. Redon J, Gomez-Sanchez MA, Baldo E, Casal MC, Fernandez ML, Miralles A et al. Microalbuminuria is correlated with left ventricular hypertrophy in male hypertensive patients. J Hypertens 1991; 9(suppl 6):S148-9.
78. Bigazzi R, Bianchi S, Nenci R, Baldari D, Baldari C, Campese VM. Increased thickness of the carotid artery in patients with essential hypertension and microalbuminuria. J Hum Hypertens 1995; 9:827-33.
79. Agrawal B, Berger A, Wolf K, Luft FC. Microalbuminuria screening by reagent strips predicts cardiovascular risk in hypertension. J Hypertens 1996; 14:223-8.
80. Deckert T, Feldt-Rasmusen B, Borch-Jorch Johnsen K, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage: The Steno hypothesis. Diabetologia 1989; 32:219-26.
81. Parving HH, Gyntelberg F. Transcapilary escape rate of albumin and plasma volume in essential hypertension. Circ Res 1973; 32:642-51.
82. Pedersen EB, Mogensen CE. Effects of antihypertensive treatment on urinary albumin excretion, glomerular filtration rate and renal plasma flow in patients with arterial hypertension. Scand J Clin Lab Invest 1976; 36:231-7.
83. Pedrinelli R, Giampetro O, Carmassi F, Melillo E, Del' Omo G, Catapano G, et al. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet 1994; 344:14-18.
84. Kario K, Matsuo T, Kobayashi H, Matsuo M, Sakata T, Miyata T, et al. Factor VII hyperactivity and endothelial cell damage are found in elderly hypertensives only when concomitant with microalbuminuria. Arterioscler Thromb Vasc Biol 1996; 16(3):455-61.
85. Taddei S, Virdis A, Mattei P, Ghiadoni L, Sudano I, Arrhigi P, et al. Lack of correlation between microalbuminuria and endothelial function in essential hypertensive patients. J Hypertens 1995; 13(9):1003-8.
86. Agewall S, Wilkstrand J, Ljungman S, Herlitz H, Fagerberg B. Does microalbuminuria predict cardiovascular events in non diabetic men with treated hypertension? Risk Factor Intervention Study Group. Am J Hypertens 1995; 8(4):337-42.
87. Palatini P, Graniero G, Mormino P, Mattarei M, Sanzuol F, Cignacco G, et al. Prevalence and clinical correlates of Microalbuminuria in Stage I Hypertension. Results from the Hypertension and Ambulatory Recording Venetia Study (HARVEST study). Am J Hypertens 1996; 9:334-41.
88. Redon J, Liao Y, Lzano J, Miralles A, Baldo E, Cooper R. Factors related to the presence of microalbuminuria in essential hypertension. Am J Hypertens 1994; 7:801-7.
89. Biesenbach C, Zazgornik J. High prevalence of hypertensive retinopathy and coronary heart disease in hypertensive patients with persistent microalbuminuria under short intensive therapy. Clin Nephrol 1994; 41(4):211-18.
90. Bigazzi R, Bianchi S, Baldari D, Sgherri G, Baldari G, Campese VM. Microalbuminuria in salt sensitive patients. A marker for renal and cardiovascular risk factors. Hypertension 1994; 23(2):195-9.
91. Bray JA. Complications of obesity. Ann Int Med 1985; 103:1052-62.
92. Drenick EJ, Bale GS, Seltzr EF, Johnson DJ. Excessive mortality and causes of death in morbidly obese men. JAMA 1980; 243:443-5.
93. Brenner BM. Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int 1983; 23:647-55.
94. Goldszer R, Irvine J, Lazarus JM, Gottlieb M, Solomon H. Renal findings in obese humans (Abs). Kidney Int 1984; 24:165.
95. Jennette JC, Charles L, Grubb W. Glomerulomegaly and focal segmental glomerulosclerosis associated with obesity and sleep-apnea syndrome. Am J Kidney Dis 1987; 10:470-2.
96. Lokkegaard N, Haupter I, Kristensen T. Microalbuminuria in obesity. Scand J Urol Nephrol 1992; 26:275-8.
97. Basdevant A, Cassuto D, Gibault T, Raison J, Guy Grand B. Microalbuminuria and body fat distribution in obese subjects. Int J Obes Relat Metab Disord 1994; 18(12):806-11.
98. Pontremoli R, Cheli V, Sofia A, Tirotta A, Ravera M, Nicolella C, et al. Prevalence of micro-and macroalbuminuria and their relationship with other cardiovascular risk factors in essential hypertension. Nephrol Dial Transplant 1995; 10(suppl 6):6-9.
99. Microalbuminuria Collaborative Study Group, United Kingdom. Risk factors for development of microalbuminuria in insulin dependent diabetic patients: a cohort study. Br Med J 1993; 306:1235-9.
100. Klein R, Klein B, Lynton K, Moss S. Microalbuminuria in a population based study of diabetes. Arch Intern Med 1992; 152:153-8.
101. Almdal T, Norgaard K, Rasmussen-Feldt B, Deckert T. The predictive value of microalbuminuria in IDDM. Diabetes Care 1994; 17(2):120-5.
102. Agewall S, Fagerberg S, Attvall S, Ljungman S, Urbanavicius V, Tengborn L, Wikstrand J. Microalbuminuria, insulin sensitivity and hemostatic factors in non-diabetic treated hypertensive men. J Intern Med 1995; 237:195-203.
103. Corradi L, Zoppi R, Tettamanti F, Malamani GD, Lazzari P, Fogari R. Smoking habit and microalbuminuria in hypertensive patients with type 2 diabetes mellitus. J Hypertens 1993; 11(suppl 5):S190-1.
104. Blann AD. Increased circulating levels of von Willebrand factor antigen in smokers may be due to lipid peroxides. Med Sci Res 1991; 19:535-6.
105. Nitenberg A, Antoni I, Foult JM. Acetylcholine-induced coronary vasoconstriction in young heavy smokers with normal coronary arteriographic findings. Am J Med 1993; 95:71-7.
106. Bianchi S, Bigazzi R, Baldari G, Campese VM. Microalbuminuria in patients with essential hypertension: effects of an angiotensin converting enzyme inhibitor and of a calcium channel blocker. Am J Hypertens 1991; 4:291-6.
107. Puig J, Mateos F, Ramos T, Lavilla MP, Capitan MC, Gil A. Albumin excretion rate and metabolic modifications in patients with essential hypertension. Effects of two angiotensin converting enzyme inhibitors. Am J Hypertens 1994; 7:46-51.
108. Persson B, Anderson OK, Wysocki M, Hedner T, Karlberg B. Calcium antagonism in essential hypertension: effect on renal haemodynamics and microalbuminuria. J Intern Wed 1993; 231(3):247-52.
109. Erley CM, Hefele U, Braun N, Risler T. Microalbuminuria in essential hypertension; reduction by different antihypertensive drugs. Hypertension 1993; 21:810-15.
110. Hartford M, Wendelhag I, Berglund G, Wallentin I, Ljungman S, Wikstrand J. Cardiovascular and renal effects of long term antihypertensive treatment. JAMA 1988; 259:2553-7.
111. Yudkin J, Forrest D, Jackson C. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes survey. Lancet 1988; ii:530-3.
112. Damsgaard E, Froland A, Jorgensen OL, Mogensen CE. Microalbuminuria as predictor of increased mortality in elderly people. Br Med J 1990; 300:297-300.
113. Metcalf P, Baker J, Scott A, Wild C, Scragg R, Dryson A. Albuminuria in people at least 40 years old: Effect of obesity, hypertension and hyperlipidemia. Clin Chem 1992; 38(9):1802-8.
114. Kuusisto J, Mykkanen L, Pyorala K, Laakso M. Hyperinsulinemic microalbuminuria. A new Risk indicator for coronary heart disease. Circulation 1995; 91:831-7.